Search
for
Sort by
Research 301–330 of 1000+
- Role of janus kinase inhibitors in the treatment of alopecia areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Phenyl Propanoid 1’s-1′-Acetoxychavicol Acetate Protects Against Testosterone-Induced Alopecia by Inhibiting Nadph Oxidase
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- In Vitro Skin Penetration of 5α-Reductase Inhibitors from Tectona grandis L.f. Leaf Extracts
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Hair Growth Promoting Effects of 15-Hydroxyprostaglandin Dehydrogenase Inhibitor in Human Follicle Dermal Papilla Cells
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- CXCL12 inhibits hair growth through CXCR4
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Interleukin-6 Null Mice Paradoxically Display Increased STAT3 Activity and Wound-Induced Hair Neogenesis
- Wound healing protects against chemotherapy-induced alopecia in young rats via up-regulating interleukin-1β-mediated signaling
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- STAT3 Partly Inhibits Cell Proliferation via Direct Negative Regulation of FST Gene Expression
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study
- Hyperinnervation inhibits organ-level regeneration in mammalian skin
- The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle